Cargando…
Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729842/ https://www.ncbi.nlm.nih.gov/pubmed/36597976 http://dx.doi.org/10.1136/rmdopen-2022-002567 |
| _version_ | 1784845559097458688 |
|---|---|
| author | ten Hagen, Alexander Habermann, Elisa Hermann, Sandra Burmester, Gerd R Biesen, Robert Albach, Fredrik N. |
| author_facet | ten Hagen, Alexander Habermann, Elisa Hermann, Sandra Burmester, Gerd R Biesen, Robert Albach, Fredrik N. |
| author_sort | ten Hagen, Alexander |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9729842 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97298422022-12-08 Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series ten Hagen, Alexander Habermann, Elisa Hermann, Sandra Burmester, Gerd R Biesen, Robert Albach, Fredrik N. RMD Open Epidemiology BMJ Publishing Group 2022-12-06 /pmc/articles/PMC9729842/ /pubmed/36597976 http://dx.doi.org/10.1136/rmdopen-2022-002567 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Epidemiology ten Hagen, Alexander Habermann, Elisa Hermann, Sandra Burmester, Gerd R Biesen, Robert Albach, Fredrik N. Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series |
| title | Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series |
| title_full | Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series |
| title_fullStr | Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series |
| title_full_unstemmed | Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series |
| title_short | Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series |
| title_sort | mild covid-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced b cell depletion: a case series |
| topic | Epidemiology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729842/ https://www.ncbi.nlm.nih.gov/pubmed/36597976 http://dx.doi.org/10.1136/rmdopen-2022-002567 |
| work_keys_str_mv | AT tenhagenalexander mildcovid19despiteinadequateantibodyresponseafterrepeatedvaccinationsinrheumaticdiseasepatientswithrituximabinducedbcelldepletionacaseseries AT habermannelisa mildcovid19despiteinadequateantibodyresponseafterrepeatedvaccinationsinrheumaticdiseasepatientswithrituximabinducedbcelldepletionacaseseries AT hermannsandra mildcovid19despiteinadequateantibodyresponseafterrepeatedvaccinationsinrheumaticdiseasepatientswithrituximabinducedbcelldepletionacaseseries AT burmestergerdr mildcovid19despiteinadequateantibodyresponseafterrepeatedvaccinationsinrheumaticdiseasepatientswithrituximabinducedbcelldepletionacaseseries AT biesenrobert mildcovid19despiteinadequateantibodyresponseafterrepeatedvaccinationsinrheumaticdiseasepatientswithrituximabinducedbcelldepletionacaseseries AT albachfredrikn mildcovid19despiteinadequateantibodyresponseafterrepeatedvaccinationsinrheumaticdiseasepatientswithrituximabinducedbcelldepletionacaseseries |